Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Tackling reproducibility in academic preclinical drug discovery


The reproducibility of biomedical research on novel drug targets has become suspect. Here, we highlight how drug discovery centres embedded in academic institutions, but with a translational imperative, can help address this reproducibility crisis.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Dolgin, E. Drug discoverers chart path to tackling data irreproducibility. Nat. Rev. Drug Discov. 13, 875–876 (2014).

    Article  CAS  Google Scholar 

  2. Prinz, F., Schlange, T. & Asadullah, K. Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712 (2011).

    Article  CAS  Google Scholar 

  3. Errington, T. M. et al. An open investigation of the reproducibility of cancer biology research. eLife 3,, (2014).

  4. Baell, J. & Walters, M. A. Chemical con artists foil drug discovery. Nature 513, 481–483 (2014).

    Article  CAS  Google Scholar 

  5. Arrowsmith, C. H. et al. The promise and peril of chemical probes. Nat. Chem. Biol. 11, 536–541 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Stephen V. Frye.

Ethics declarations

Competing interests

The authors are either members or board members of the Academic Drug Discovery Consortium.

Related links

Related links


Academic Drug Discovery Consortium

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frye, S., Arkin, M., Arrowsmith, C. et al. Tackling reproducibility in academic preclinical drug discovery. Nat Rev Drug Discov 14, 733–734 (2015).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research